Literature DB >> 13152203

Plasma volume changes following the administration of albumin to patients with the nephrotic syndrome.

F P CHINARD, H D LAUSON, H A EDER, R L GREIF.   

Abstract

Entities:  

Keywords:  ALBUMIN/effects; BLOOD VOLUME; GLOMERULONEPHRITIS

Mesh:

Substances:

Year:  1954        PMID: 13152203      PMCID: PMC1087279          DOI: 10.1172/JCI102934

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  Relationship of the renal clearances of T-1824 and of albumin in some patients with proteinuria.

Authors:  F P CHINARD; H D LAUSON; H A EDER
Journal:  J Clin Invest       Date:  1952-10       Impact factor: 14.808

2.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VI. THE OSMOTIC PRESSURE OF PLASMA AND OF SERUM ALBUMIN.

Authors:  G Scatchard; A C Batchelder; A Brown
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

3.  The colloid osmotic pressure of serum.

Authors:  G SCATCHARD
Journal:  Science       Date:  1951-02-23       Impact factor: 47.728

  3 in total
  4 in total

1.  Starling's hypothesis in the formation of edema.

Authors:  F P CHINARD
Journal:  Bull N Y Acad Med       Date:  1962-06

2.  A study of the mechanisms of edema formation in patients with the nephrotic syndrome.

Authors:  H A EDER; H D LAUSON; F P CHINARD; R L GREIF; G C COTZIAS; D D VAN SLYKE
Journal:  J Clin Invest       Date:  1954-04       Impact factor: 14.808

3.  A study on the mechanism of proteinuria in patients with the nephrotic syndrome.

Authors:  F P CHINARD; H D LAUSON; H A EDER; R L GREIF; A HILLER
Journal:  J Clin Invest       Date:  1954-04       Impact factor: 14.808

4.  Cellular mechanisms of protein metabolism in the nephron. VII. The characteristics and significance of the protein absorption droplets (hyaline droplets) in epidemic hemorrhagic fever and other renal diseases.

Authors:  J OLIVER; M MACDOWELL
Journal:  J Exp Med       Date:  1958-05-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.